COMPANY

Syncromune

HQ: Fort Lauderdale, FL source · syncromune.com ↗

Company-reported stage: Phase 2 · source · Oct 12, 2026

1 open job · last seen Oct 23, 2026 · 1 source

Keywords: oncology metastatic solid tumor metastatic solid tumors Metastatic Castration-resistant Prostate Cancer SV-102

Location: Fort Lauderdale, FL · source · Oct 13, 2026

Profile checked Oct 10, 2026

1Open jobs 1Trials (company is sponsor)

Hiring

Title	Location (from posting)	Employer posted	First seen
Associate Director, Drug Product Development	Remote	Not stated	Oct 11, 2026

See all 1 job

Timeline

May 29, 2025 Trial start Phase 2: A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer source ↗

Upcoming milestones

Apr 14, 2028 (ESTIMATED) · Phase 2 · A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer · NCT06533644

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT06533644	A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer	Phase 2	Recruiting	May 29, 2025	Apr 14, 2028 (estimated)

Open jobs 1

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
Associate Director, Drug Product Development	Remote	Not stated	Oct 11, 2026	Senior

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at Syncromune on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18